Kymera Therapeutics slides after launching $500 million share offering

Kymera Therapeutics

09/12/2025 16:46

** Drug developer Kymera Therapeutics' KYMR.O shares slide 7% to $87.71

** KYMR late Monday launched a stock offering of $500 million worth of shares

** Stock closed up 41.6% on Monday after positive data for eczema drug

** Morgan Stanley, J.P. Morgan, Jefferies, Stifel, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for offering

** Proceeds will be used to advance its pipeline of preclinical and clinical degrader programs and for other purposes

** KYMR had 71.7 million outstanding shares as of September 30, according to prospectus

** All 23 brokerages covering the stock rate it "buy" or higher; median PT $90.50 - data compiled by LSEG

** As of last close, KYMR stock was up 134.4% YTD

 (Reporting by Arasu Kannagi Basil in Bengaluru)

 ((ArasuKannagi.Basil@thomsonreuters.com))